Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-10-21

Clinical Trial Update: Trans-Abdominal Fetal Pulse Oximetry - EFS-IDE [EARLY_Phase 1]

View source ↗

Summary

Raydiant Oximetry reports the completion of an early-phase 1 trial evaluating trans-abdominal fetal pulse oximetry (EFS-IDE). The study focuses on fetal hypoxia…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Raydiant Oximetry, Inc. | Conditions: Fetal Hypoxia, Fetal Distress | EARLY_Phase 1 | Status: COMPLETED